# A Study of MG-K10 in Subjects With Asthma

> **NCT05382910** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shanghai Mabgeek Biotech.Co.Ltd** · enrollment: 180 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MG-K10
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05382910
- **Lead sponsor:** Shanghai Mabgeek Biotech.Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-05
- **Primary completion:** 2023-12-20
- **Final completion:** 2024-06-20
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05382910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05382910, "A Study of MG-K10 in Subjects With Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05382910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*